Eli Lilly and Company (LLY) reported Q1 non-GAAP earnings Thursday of $3.34 per diluted share, up from $2.58 a year earlier.

Analysts polled by FactSet expected $3.26.

Revenue for the quarter ended March 31 was $12.73 billion, compared with $8.77 billion a year earlier.

Analysts surveyed by FactSet expected $12.67 billion.

The company trimmed its 2025 adjusted earnings guidance to $20.78 to $22.28 per diluted share from $22.50 to $24. Analysts surveyed by FactSet expect $22.22. The company reaffirmed its annual revenue guidance of $58 billion to $61 billion. Analysts polled by FactSet expect $59.72 billion.

Shares of the company fell over 3% in recent premarket activity.